tm logo
MYMELDI
REGISTERED

on 01 Dec 2021

Last Applicant/ Owned by

ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED

Clonshaugh Business and Technology ParkDublin 17D17 E400

IE

Serial Number

1925292 filed on 15th Oct 2018

Registration Number

TMA1115174 registered on 01st Dec 2021

Registration expiry Date

01st Dec 2031

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

MYMELDI

Trademark usage description

pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, facial asymmetri Read More

Classification Information


Class [005]
Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, facial asymmetries and defects and conditions of the human skin, namely stretch marks, birthmarks, scarring, volume loss, and skin pigmentation diseases and disorders, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; pharmaceutical preparations for the treatment of neurological disorders, namely Huntington's Disease, brain injury, spinal cord injury and seizure disorders, muscle dystonia, smooth muscle disorders, namely inflammatory bowel disease, connective tissue diseases, and autoimmune diseases, disorders of the autonomic nervous system, headaches, hyperhidrosis, sports injuries, namely fractures, sprains, cartilage injuries, dislocated joints and muscle soreness, cerebral palsy, muscle spasms, muscle tremors caused by Huntington's Disease, brain injury, spinal cord injury and seizure disorders and pain; dermatological formulations, namely, medicated dry skin lotions and creams for treating eczema, psoriasis and dermatitis, acne medications and medicated skin lightener lotions and creams for treatment of skin pigmentation diseases; oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth and pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing pharmaceutical preparations; pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; pharmaceutical preparations and medicines for the treatment of sensory organ disorders, namely ophthalmological diseases and disorders, ocular disorders, bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, dermatitis, skin pigmentation diseases, pharmaceutical preparations for the treatment of skin irritations, sunburn, rashes, and acne; pharmaceutical preparations and medicines for the treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, Parkinson's disease; pharmaceutical preparations and medicines for the treatment of urogenital organ disorders, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction; pharmaceutical preparations and medicines for the treatment of circulatory system disorders, namely vascular diseases and heart disease; pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders, namely dermatitis, skin pigmentation diseases, eczema, psoriasis and rosacea; pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; pharmaceutical preparations that support, encourage and promote bone strength and bone health and which are used in the treatment of bone disorders and bone diseases; antibiotics; antifungal preparations; antivirals and antiprotozoals; pharmaceutical preparations for the prevention and treatment of bacterial skin and urinary tract infections; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neurodegenerative nerve diseases and disorders, namely multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy, cerebral palsy, brain injury, spinal cord injury, seizure disorders, dementia; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders, namely diabetic neuropathy, Guillain-Barré syndrome, acute motor axonal neuropathy, botulism, Charcot-Marie-Tooth disease, leprosy; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, and depression; neuroprotective agents, namely pharmaceutical preparations to prevent damage to the brain and spinal cord; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; pharmaceutical preparations for the treatment of hypothyroidism; pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body used in connection with anti-aging, namely for use in the treatment of glabellar lines, facial wrinkles, asymmetrical defects and conditions of the human skin, namely stretch marks, birthmarks, scarring, volume loss, and skin pigmentation diseases and disorders and for use in connection with the treatment of dermatitis, skin pigmentation diseases, skin wounds, bacterial skin infections, viral skin infections, parasitic skin infections, skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, eczema, rosacea, acne and psoriasis, for hydrating the skin during pregnancy, and preparations for cleaning the skin for medical use


Classification kind code

11

Mark Details


Serial Number

1925292

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 191
on 15th Sep 2021
Registration Fee Notice Sent
Submitted for opposition 190
on 15th Sep 2021
Registration Pending
Submitted for opposition 42
on 23rd Jun 2021
Advertised
Submitted for opposition 27
on 27th May 2021
Approval Notice Sent
Submitted for opposition 26
on 27th May 2021
Approved
Submitted for opposition 22
on 11th Mar 2021
Search Recorded
Submitted for opposition 20
on 11th Mar 2021
Examiner's First Report
Submitted for opposition 31
on 24th Oct 2018
Formalized
Submitted for opposition 1
on 16th Oct 2018
Created
Submitted for opposition 30
on 15th Oct 2018
Filed